Activating mutations have been introduced in the sonic hedgehog pathway in SmoA1 and Ptch+/− mice, and these mice are frequently used as in vivo model systems to study medulloblastoma development and therapy. This evidence concerns the gene PTCH1 and medulloblastoma.